A phase 2a study evaluating the efficacy and safety of sutetinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring uncommon EGFR mutations.
Sutetinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase 2a study evaluating the efficacy and safety of sutetinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring uncommon EGFR mutations. ### Output: Sutetinib